EUVIMED · CrossrefJournal
Seminars in Oncology
ISSN 0093-7754 · Elsevier BV
Latest articles
Single-cell sequencing in pan-cancer research: Decoding heterogeneity, tumor microenvironment, and clinical translation
Tumour immunotherapy in solid and hematologic malignancies: Progress, challenges, and a practical framework
The role of fumarate and itaconate in tumor microenvironment
Integrating patient-reported outcomes into explainable machine learning models for long-term survival prediction in TKI-treated metastatic renal cell carcinoma
Spatiotemporal decoding of the pre-metastatic niche: Multi-omics innovations and clinical horizons
Dual alexithymia: A relational framework for clinical communication in oncology
Rhabdomyolysis resulting from the interaction of rosuvastatin and abiraterone: A case study
SPIB as a context–specific regulator in cancer: from molecular mechanisms to clinical implications
Early hepatic decompensation is associated with mortality in patients with HCC treated with atezolizumab plus bevacizumab or durvalumab plus tremelimumab
NK3 subsets are linked to NK cell exhaustion and immunotherapy responsiveness in tumor
Oncolytic viruses in gastrointestinal malignancies: Clinical progress, translational challenges, and future directions
Microbiome oncolytic virus interactions in cancer: emerging evidence and therapeutic implications for immunotherapy
Bone metastasis in cancer: from microenvironmental remodeling to precision therapy
Refining MRI-guided surgical strategy for borderline low rectal cancer: Beyond baseline imaging and oncologic endpoints
Pretreatment platelet count exhibits a U-shaped association with outcomes after immune checkpoint blockade with a mid-range stratum for dual-checkpoint immunotherapy
Immunotherapy in multiple myeloma: Molecular mechanisms, current clinical strategies, resistance, and future perspectives
Mutation-associated cGAS-STING signaling and the co-evolution of the tumor immune microenvironment in DNA damage repair-deficient tumors: from spatial architecture to bedside translation
Early pembrolizumab as salvage therapy in EMA-CO-refractory ultra-high-risk gestational choriocarcinoma
The Frozen Section Debate in Head and Neck Cancer: Evidence, Limitations, and Future Directions
Plasma lipid species and breast cancer phenotypes: a two-sample Mendelian randomization analysis with multiplicity and sensitivity assessment
Interplay of Oncogenic Pathways in Colorectal Cancer: Mechanisms Driving Progression and Drug Resistance
No Recurrent Severe Immune-Related Hepatitis During PD-L1 Therapy After PD-1-Related Hepatitis in Advanced Gastroesophageal Junction Adenocarcinoma: A Case Report
Cancer-associated fibroblasts in bladder cancer: Immunosuppressive mechanisms and therapeutic targeting
Targeting TREM2+tumor-associated macrophages reactivates antitumor immunity and improves anti-PD-1 efficacy in gastric cancer
Machine learning-based integration develops a lactate metabolism related gene signature for improving outcomes in pancreatic ductal adenocarcinoma
Colchicine as an anti-inflammatory agent improving cancer prognosis: A therapeutic repurposing perspective
Purine metabolism in tumorigenesis and its clinical implications
Tumor tough, therapy smarter: Rethinking CAR-T for pancreatic cancer
Mapping the epidemiology of cancer-related anemia: A systematic scoping review of global prevalence and incidence
Artificial intelligence-driven intelligent nanocarriers for cancer theranostics: A paradigm shift with focus on brain tumors
EUVIMED